Ottawa Hospital Research Institute

$217,937.00 CAD

≈ 3 Canadians' average pay for a year
Department
National Research Council Canada
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient country
Canada
Fiscal year
2021-2022
Agreement period
January 25, 2022 – October 31, 2023
Reference
nrc-cnrc:172-2021-2022-Q1-986038

Published purpose

This project will support the development, validation, qualification and execution of a number of release assays critical to the release of the GMP lentiviral vector that will be used to generate a next generation CAR-T cell product (CD22) to be tested in a clinical trial extending across Canada. Manufacturing of the lentiviral product is scheduled to start February 2022.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions